Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ELDN holding history

Eledon Pharmaceuticals, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELDN overviewAll 13F holders of ELDNFull Q2 2026 holdings

Shares (Q2 2026)
200,900
Value
$791.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELDN by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026200,900$791.5K<0.1%+176,300+716.7%AddedHolders
Q1 202624,600$75.8K<0.1%−152,390−86.1%ReducedHolders
Q4 2025176,990$267.3K<0.1%−172,210−49.3%ReducedHolders
Q3 2025349,200$904.4K<0.1%+158,527+83.1%AddedHolders
Q2 2025190,673$516.7K<0.1%+67,900+55.3%AddedHolders
Q1 2025122,773$416.2K<0.1%−24,400−16.6%ReducedHolders
Q4 2024147,173$606.4K<0.1%+11,300+8.3%AddedHolders
Q3 2024135,873$338.3K<0.1%−900−0.7%ReducedHolders
Q2 2024136,773$361.1K<0.1%+49,704+57.1%AddedHolders
Q1 202487,069$179.0K<0.1%+17,896+25.9%AddedHolders
Q4 202369,173$125.0K<0.1%+7,200+11.6%AddedHolders
Q3 202361,973$85.0K<0.1%+1,600+2.7%AddedHolders
Q2 202360,373$83.0K<0.1%+28,200+87.7%AddedHolders
Q1 202332,173$76.0K<0.1%+2,500+8.4%AddedHolders
Q4 202229,673$68.0K<0.1%−2,200−6.9%ReducedHolders
Q3 202231,873$88.0K<0.1%−300−0.9%ReducedHolders
Q2 202232,173$79.0K<0.1%+13,700+74.2%AddedHolders
Q1 202218,473$73.0K<0.1%+4,800+35.1%AddedHolders
Q4 202113,673$60.0K<0.1%−25,990−65.5%ReducedHolders
Q3 202139,663$245.0K<0.1%+18,556+87.9%AddedHolders
Q2 202121,107$167.0K<0.1%−5,944−22.0%ReducedHolders
Q1 202127,051$289.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.